English    Français

Comprehensive Patient Care in the Treatment of Ulcerative Colitis


Marc Bradette, MD, FRCPC, CSPQ, Clinical Professor, Department of Gastroenterology, Pavillon Hôtel-Dieu de Québec, Québec, QC.

With this special issue of the Journal of Current Clinical Care (JCCC), we aim to provide community healthcare professionals (HCPs) with practical clinical insight and support in managing patients with ulcerative colitis (UC)—both those who are newly diagnosed as well as those who have responded to medical therapy and are in remission. The articles included here address day-to-day care for a newly or recently diagnosed population, where treatment selection with first-line therapy such as 5-Aminosalicylates (5-ASA) may be appropriate. Further, each article references concrete clinical experience, giving a sense of how real-world patient care has influenced practice. Physicians invest substantial time and resources in patient counselling and education at the time of diagnosis, and this supplement seeks to share best practices and ideas to improve both dialogue and, most importantly, clinical outcomes.

While the etiology of Ulcerative Colitis is largely unknown, it is a chronic condition for which there is no cure. Upon learning of their diagnosis, patients may struggle to accept the limitations often imposed by such chronic conditions, and incomplete information regarding prognosis and treatment options only further interferes with ongoing care—trouble that often manifests around medication adherence. Newly diagnosed patients need their physicians' counselling and support. Patients have many questions about their condition, and studies show that the better they understand their disease and its management, the more they adhere to treatment regimens. Yet many practitioners are forced to guesstimate, through trial and error, how much time is required to optimize the impact from patient counselling.